This inventor holds 1 USPTO granted patent. Top assignee: Beacle, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Chinatsu Ohashi: Innovator in Virus-Like Particle Technology
Introduction: Chinatsu Ohashi is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of immunology through her innovative research and development of virus-like particles. Her work focuses on creating solutions that can trigger immune responses against various genotypes of hepatitis B virus (HBV).
Latest Patents: Chinatsu Ohashi holds a patent for "Virus-like particles including HBs-L antigen protein for causing immune response against HBV." This invention provides a virus-like particle comprising several types of HBs-L antigen proteins. The goal is to offer an antigen that effectively triggers an immune reaction against HBV, which is crucial for combating this viral infection.
Career Highlights: Throughout her career, Chinatsu has demonstrated a strong commitment to advancing medical science. Her work at Beacle, Inc. has positioned her as a key player in the development of innovative therapeutic solutions. She has successfully translated her research into practical applications that can benefit public health.
Collaborations: Chinatsu collaborates with esteemed colleagues, including Yasumasa Goh and Yasunori Oda. These partnerships enhance her research efforts and contribute to the overall success of her projects.
Conclusion: Chinatsu Ohashi is a trailblazer in the field of immunology, with a focus on developing virus-like particles to combat HBV. Her innovative work and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile